ClinicalTrials.gov
public full text
Public Domain
Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19
The purpose of this trial is to assess the safety and toxicity profile of the combination of famotidine and oral n-acetyl cysteine in adult outpatients with newly diagnosed SARS-CoV-2 infection.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in Community#801539
- To Observe Whether Isoflurane Can Treat COVID-19 Patients#892497
- Calcifediol in the Treatment of COVID 19#1101278
- Role of Famotidine in the Clinical Improvement of COVID-19 Patients.#1126138
- Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19#1382314
Record · ID 1419560
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive